Document is current
Any future updates will be listed below
-
Authors
Alameda, Luis https://orcid.org/0000-0002-8621-2885
Rodriguez, Victoria
Di Forti, Marta https://orcid.org/0000-0002-3218-6925
Spinazzola, Edoardo
Trotta, Giulia
Arango, Celso https://orcid.org/0000-0003-3382-4754
Arrojo, Manuel
Bernardo, Miguel https://orcid.org/0000-0001-8748-6717
Bobes, Julio https://orcid.org/0000-0003-2187-4033
de Haan, Lieuwe
Del-Ben, Cristina Marta https://orcid.org/0000-0003-0145-9975
Gayer-Anderson, Charlotte
Sideli, Lucia
Jones, Peter B. https://orcid.org/0000-0002-0387-880X
Kirkbride, James B. https://orcid.org/0000-0003-3401-0824
La Cascia, Caterina
Tripoli, Giada
Ferraro, Laura
La Barbera, Daniele
Lasalvia, Antonio
Tosato, Sarah https://orcid.org/0000-0002-9665-7538
Llorca, Pierre-Michel https://orcid.org/0000-0001-7438-8990
Menezes, Paulo Rossi https://orcid.org/0000-0001-6330-3314
van Os, Jim https://orcid.org/0000-0002-7245-1586
Rutten, Bart P. https://orcid.org/0000-0002-9834-6346
Santos, Jose Luis
Sanjuán, Julio
Selten, Jean-Paul
Szöke, Andrei
Tarricone, Ilaria https://orcid.org/0000-0002-5786-2520
Tortelli, Andrea
Velthorst, Eva https://orcid.org/0000-0002-9240-2909
Jongsma, Hannah E.
Vassos, Evangelos https://orcid.org/0000-0001-6363-0438
Quattrone, Diego
Murray, Robin M. https://orcid.org/0000-0003-0829-0519
Aas, Monica https://orcid.org/0000-0002-2338-5826
-
Funding
Funding for this research was provided by:
Carigest SA Foundation Adrian and Simone Frutiger
- License Information
-
More Information
Article History
Received: 7 March 2024
Revised: 20 September 2024
Accepted: 2 October 2024
First Online: 26 October 2024
Competing interests
: Dr. Bernardo has been a consultant for, received grant/research support and honoraria from, and been on the speakers/advisory board of ABBiotics, Adamed, Angelini, Abartis Pharma, Casen Recordati, Esteve Pharmaceuticals, Janssen-Cilag, Menarini, Rovi and Takeda. Dr. Arango. has been a consultant to or has received honoraria or grants from Acadia, Angelini, Gedeon Richter, Janssen Cilag, Lundbeck, Minerva, Otsuka, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion and Takeda. Dr Peter B. Jones declare to have consulted for Ricordati and Janssen. Dr Murray has received payments for non-promotional seminars from JANSSEN, SUNOVIAN, LUNDBECK AND OTSUKA. Dr Di Forti has received payments for non-promotional seminars from Recordati. Dr Alameda has received payments for non-promotional seminars from Alianza Otsuka-Lundbeck. None of the other co-authors declare any competing interests.
